MedTrace Logo

Intra-Operative Corticosteroid Injection During Arthroscopic Shoulder Surgery

NCT02867904 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2021-05-06

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy of intra-operative subacromial corticosteroid injections in patients undergoing arthroscopic shoulder surgery on quality of life scores and activity level when compared to a control group.

Conditions

  • Arthroscopic Shoulder Surgery
  • Intra-articular Debridement
  • Subacromial Decompression
  • Acromioplasty
  • Acromioclavicular Joint Resection

Interventions

DRUG

Methylprednisolone (40 mg depomedrol, 1ml, injection)

Experimental Drug

DRUG

Marcaine (4ml 0.5%, injection)

Control

Sponsors & Collaborators

  • Peter Chang

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2020-04-30
Completion
2020-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02867904 on ClinicalTrials.gov